WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of Verified Clinical Trials, LLC (“VCT” or the “Company”), the global leader in solutions addressing patient safety, compliance, and data integrity from patient enrollment through study completion. “VCT has developed a truly unique solution that proactively reduces downstream risk for all clinical research constituents – driving safety for participants, improved data quality, and reduction in preventable trial disruptions,” said CJ Burnes, Partner at WindRose.
Read the full article: WindRose Health Investors Announces Recapitalization of Verified Clinical Trials //
Source: https://www.prnewswire.com/news-releases/windrose-health-investors-announces-recapitalization-of-verified-clinical-trials-302844569.html